HK1113309A1 - Therapeutic agent for drug dependence - Google Patents

Therapeutic agent for drug dependence

Info

Publication number
HK1113309A1
HK1113309A1 HK08103420.6A HK08103420A HK1113309A1 HK 1113309 A1 HK1113309 A1 HK 1113309A1 HK 08103420 A HK08103420 A HK 08103420A HK 1113309 A1 HK1113309 A1 HK 1113309A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic agent
substance
craving
recurrence
drug dependence
Prior art date
Application number
HK08103420.6A
Other languages
English (en)
Inventor
Tsuneyuki Yamamoto
Fumio Yoneda
Kazuhiko Morimoto
Original Assignee
Nat Univ Corp Kyushu Univ
Fujimoto Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Univ Corp Kyushu Univ, Fujimoto Co Ltd filed Critical Nat Univ Corp Kyushu Univ
Publication of HK1113309A1 publication Critical patent/HK1113309A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK08103420.6A 2004-11-25 2008-03-27 Therapeutic agent for drug dependence HK1113309A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004339996A JP5030194B2 (ja) 2004-11-25 2004-11-25 薬物依存症治療剤
PCT/JP2005/021344 WO2006057211A1 (ja) 2004-11-25 2005-11-21 薬物依存症治療剤

Publications (1)

Publication Number Publication Date
HK1113309A1 true HK1113309A1 (en) 2008-10-03

Family

ID=36497948

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08103420.6A HK1113309A1 (en) 2004-11-25 2008-03-27 Therapeutic agent for drug dependence

Country Status (15)

Country Link
US (2) US7825158B2 (zh)
EP (1) EP1815853B1 (zh)
JP (1) JP5030194B2 (zh)
KR (1) KR101096416B1 (zh)
CN (1) CN101065123B (zh)
AT (1) ATE429219T1 (zh)
AU (1) AU2005308258B2 (zh)
CA (1) CA2589289C (zh)
DE (1) DE602005014135D1 (zh)
DK (1) DK1815853T3 (zh)
ES (1) ES2325790T3 (zh)
HK (1) HK1113309A1 (zh)
IL (1) IL183028A (zh)
SI (1) SI1815853T1 (zh)
WO (1) WO2006057211A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2158908B1 (en) * 2007-06-21 2013-04-24 Fujimoto Co., Ltd. Composition for transdermal administration
CN106163514B (zh) 2013-12-25 2019-07-19 藤本株式会社 注意缺陷和多动性障碍的预防及治疗剂
CA2968793C (en) 2014-12-05 2022-02-08 Semmelweis University Compounds for use in the prevention or treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003801A1 (en) 1986-11-21 1988-06-02 Glaxo Group Limited Medicaments for treatment or prevention of withdrawal syndrome
JPH03500411A (ja) 1987-10-07 1991-01-31 マトリックス テクノロジーズ インコーポレーテッド コカイン中毒の処置および治療薬
DE3930282A1 (de) 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit
JP3601898B2 (ja) 1996-02-14 2004-12-15 俊隆 鍋島 薬物依存形成抑制剤
JPH1129476A (ja) 1997-05-16 1999-02-02 Grelan Pharmaceut Co Ltd 麻薬依存抑制剤
JP4499208B2 (ja) * 1998-10-29 2010-07-07 株式会社フジモト・コーポレーション 新規な光学活性アミノペンタン誘導体
JP4691230B2 (ja) * 2000-04-11 2011-06-01 株式会社フジモト・コーポレーション 光学活性1−(ベンゾフラン−2−イル)−2−プロピルアミノペンタンの製造方法
JP4953041B2 (ja) * 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤
JP4953040B2 (ja) * 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤

Also Published As

Publication number Publication date
EP1815853A1 (en) 2007-08-08
US7825158B2 (en) 2010-11-02
WO2006057211A1 (ja) 2006-06-01
CN101065123A (zh) 2007-10-31
CA2589289A1 (en) 2006-06-01
CA2589289C (en) 2013-04-30
ATE429219T1 (de) 2009-05-15
ES2325790T3 (es) 2009-09-17
EP1815853B1 (en) 2009-04-22
DK1815853T3 (da) 2009-08-03
IL183028A0 (en) 2007-10-31
AU2005308258A1 (en) 2006-06-01
IL183028A (en) 2011-12-29
US20100298426A1 (en) 2010-11-25
CN101065123B (zh) 2012-02-15
KR101096416B1 (ko) 2011-12-21
KR20070091610A (ko) 2007-09-11
DE602005014135D1 (de) 2009-06-04
US20080004337A1 (en) 2008-01-03
SI1815853T1 (sl) 2009-10-31
US8318799B2 (en) 2012-11-27
AU2005308258B2 (en) 2011-02-24
EP1815853A4 (en) 2008-03-19
JP2006151820A (ja) 2006-06-15
JP5030194B2 (ja) 2012-09-19

Similar Documents

Publication Publication Date Title
WO2004066912A3 (en) Anti-inflammatory compositions and uses thereof
TW200619348A (en) New compound and organic light emitting device using the same(Ⅳ)
DE502006006854D1 (de) Substituierte benzo (d) isoaxol-3-yl-amin-verbindungen als analgetika
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2006027711A3 (en) Prodrugs and codrugs containing bio- cleavable disulfide linkers
WO2007001803A3 (en) Cure catalyst, composition, electronic device and associated method
WO2005121065A3 (en) DIAMINE β2 ADRENERGIC RECEPTOR AGONISTS
WO2006031893A3 (en) Fused thiophenes, methods for making fused thiophenes, and uses thereof
NL1028947A1 (nl) Gesubstitueerde methylaryl- of heteroarylamideverbindingen.
PA8629901A1 (es) Sintesis regioespecifica de derivados de 42-ester de rapamicina
EP2039737A3 (en) Organic electroluminescence device
EA200701121A1 (ru) Потенциаторы рецепторов глутамата
WO2007133633A3 (en) Crosslinkable hole-transporting materials for organic light-emitting devices
MXPA06007171A (es) Derivados de ciclohexano espirociclicos con afinidad para el receptor orl1.
TW200700319A (en) Method for purifying hydrogen chloride
IN2014MN02582A (zh)
CO5601045A2 (es) Procedimiento para la fabricacion de compuestos organicos
WO2007004092A3 (en) Novel intermediates, process for their preparation and process for the preparation of coq10 employing the said novel intermediates
ATE486071T1 (de) Azabicycloä3.1.0ühexan-derivate als modulatoren des dopamin-d3-rezeptors
WO2009069602A1 (ja) ベンズアントラセン化合物及びそれを用いた有機エレクトロルミネッセンス素子
WO2008123233A1 (ja) 感放射線樹脂組成物、アクティブマトリックス基板及びその製造方法
HK1113309A1 (en) Therapeutic agent for drug dependence
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
TW200621843A (en) Solvent composition
WO2007047539A3 (en) Localized delivery to the lymphatic system

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201128